Abstract
Lung cancer is a major cause of cancer-related death in Japan, and the overall survival rate was still poor. The majority of individuals diagnosed with lung cancer are elderly people aged ≥65 years. Although chronic inhalation of cigarette smoke is a major risk factor to the development of lung cancer, genetic factors have been implicated to account for some of the observed differences in lung cancer susceptibility. A number of studies have examined lung cancer susceptibility based on the presence of high-frequency, low-penetrance genetic polymorphisms. As exposure to harmful chemicals or reactive oxygen species via cigarette smoking is thought to contribute to the development of lung cancer, genetic polymorphisms involved in xenobiotic metabolism, DNA repair, and inflammation might be promising candidates. In order to evaluate whether the impact of genetic polymorphisms on lung cancer differs between elderly and younger people, we evaluated potential 31 genetic polymorphisms in a stratified analysis by age category (aged ≥65 and <65 years). Seven polymorphisms, namely, CYP1A1 rs4646903, CYP1A1 rs1048943, GSTM1 deletion, GSTP1 rs1695, SULTA1 rs9282861, TP53BP1 rs560191, and CRP rs2794520, were associated with lung cancer risk in the elderly. However, there was little difference in the impact of polymorphism on lung cancer risk between the elderly and non-elderly groups. In this chapter, we would like to discuss the importance of the prevention of smoking (the best established and strongest avoidable risk factor) at early age for successful aging.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Health, Labour and Welfare Statistics Association. Trend of national health 2017/2018. Tokyo: Health, Labour and Welfare Statistics Association; 2017 (in Japanese).
Thun MJ, Henley SJ. Tobacco. In: Schottenfeld D, Fraumeni Jr JF, editors. Cancer epidemiology and prevention. New York: Oxford University Press; 1996. p. 217–42.
Gajalakshmi CK, Jha P, Ranson K, Nguyen S. Global patterns of smoking and smoking-attributable mortality. In: Jha P, Chalouplca F, editors. Tobacco control in developing countries. New York: Oxford University Press; 2000. p. 11–39.
Boffetta P, Trichopoulos D. Cancer of the lung, larynx, and pleura. In: Adami HO, Hunter D, Trichopoulos D, editors. Text of cancer epidemiology. New York: Oxford University Press; 2002. p. 248–80.
World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington, DC: AICR/WCRF; 2007.
http://epi.ncc.go.jp/files/02_can_prev/matrix_170801JP.pdf (ver. 20170801).
Washio M, Tanaka Y, Inomata S, Takahashi H, Saitoh S, Miura T, et al. Smoking increases the risk of lung cancer while green tea and green and yellow vegetables reduces the risk: a case-control study of lung cancer in Hokkaido. Rinsho To Kenkyu. 2016;93(1):93–6 (in Japanese).
Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst. 1981;66(6):1191–308.
Tafani M, Sansone L, Limana F, Arcangeli T, De Santis E, Polese M, et al. The interplay of reactive oxygen species, hypoxia, inflammation, and sirtuins in cancer initiation and progression. Oxidative Med Cell Longev. 2016;2016:3907147. https://doi.org/10.1155/2016/3907147.
Nebert DW. Role of genetics and drug metabolism in human cancer risk. Mutat Res. 1991;247(2):267–81.
Bartsch H, Nair J. Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: role of lipid peroxidation, DNA damage, and repair. Langenbeck’s Arch Surg. 2006;391(5):499–510. https://doi.org/10.1007/s00423-006-0073-1.
Smith CJ, Perfetti TA, King JA. Perspectives on pulmonary inflammation and lung cancer risk in cigarette smokers. Inhal Toxicol. 2006;18(9):667–77. https://doi.org/10.1080/08958370600742821.
Barrera G. Oxidative stress and lipid peroxidation products in cancer progression and therapy. ISRN Oncol. 2012;2012:137289. https://doi.org/10.5402/2012/137289.
Kiyohara C, Yamamura KI, Nakanishi Y, Takayama K, Hara N. Polymorphism in GSTM1, GSTT1, and GSTP1 and susceptibility to lung cancer in a Japanese population. Asian Pac J Cancer Prev. 2000;1(4):293–8.
Kiyohara C, Takayama K, Nakanishi Y. CYP2A13, CYP2A6, and the risk of lung adenocarcinoma in a Japanese population. J Health Sci. 2005;51(6):658–66. https://doi.org/10.1248/jhs.51.658.
Kiyohara C, Horiuchi T, Miyake Y, Takayama K, Nakanishi Y. Cigarette smoking, TP53 Arg72Pro, TP53BP1 Asp353Glu and the risk of lung cancer in a Japanese population. Oncol Rep. 2010;23(5):1361–8.
Kiyohara C, Horiuchi T, Takayama K, Nakanishi Y. IL1B rs1143634 polymorphism, cigarette smoking, alcohol use, and lung cancer risk in a Japanese population. J Thorac Oncol. 2010;5(3):299–304. https://doi.org/10.1097/JTO.0b013e3181c8cae3.
Kiyohara C, Horiuchi T, Takayama K, Nakanishi Y. Genetic polymorphisms involved in carcinogen metabolism and DNA repair and lung cancer risk in a Japanese population. J Thorac Oncol. 2012;7(6):954–62. https://doi.org/10.1097/JTO.0b013e31824de30f.
Kiyohara C, Horiuchi T, Takayama K, Nakanishi Y. Genetic polymorphisms involved in the inflammatory response and lung cancer risk: a case-control study in Japan. Cytokine. 2014;65(1):88–94. https://doi.org/10.1016/j.cyto.2013.09.015.
Kakino K, Kiyohara C, Horiuchi T, Nakanishi Y. CYP2E1 rs2031920, COMT rs4680 polymorphisms, cigarette smoking, alcohol use and lung cancer risk in a Japanese population. Asian Pac J Cancer Prev. 2016;17(8):4063–70.
Yamamoto Y, Kiyohara C, Suetsugu-Ogata S, Hamada N, Nakanishi Y. Biological interaction of cigarette smoking on the association between genetic polymorphisms involved in inflammation and the risk of lung cancer: a case-control study in Japan. Oncol Lett. 2017;13(5):3873–81. https://doi.org/10.3892/ol.2017.5867.
Holman CD, English DR, Milne E, Winter MG. Meta-analysis of alcohol and all-cause mortality: a validation of NHMRC recommendations. Med J Aust. 1996;164(3):141–5.
Benedetti A, Parent ME, Siemiatycki J. Lifetime consumption of alcoholic beverages and risk of 13 types of cancer in men: results from a case-control study in Montreal. Cancer Detect Prev. 2009;32(5–6):352–62.
Kiyohara C, Nakanishi Y, Takayama K, Horiuchi T, Miyake Y. Molecular epidemiologic study of lung cancer on interaction between smoking and genetic factors. The 2009 Grant-in-Aid for Scientific Research (B) Report (Grant Number: 7390175), Japan Society for the Promotion of Science [cited 1 Feb 2018]. https://kaken.nii.ac.jp/file/KAKENHI-PROJECT-17390175/17390175seika.pdf (in Japanese).
Kiyohara C, Nakanishi Y, Horiuchi T, Takayama K. Genome epidemiologic study on lung cancer and estrogen-related genes. The 2017 Grant-in-Aid for Scientific Research (B) Report (Grant Number: 25293143), Japan Society for the Promotion of Science [cited 1 Feb 2018]. https://kaken.nii.ac.jp/file/KAKENHI-PROJECT-25293143/25293143seika.pdf (in Japanese).
Kiyohara C, Nakanishi Y, Takayama K, Horiuchi T. Genome epidemiologic study on lung cancer and inflammation-related genes. The 2013 Grant-in-Aid for Scientific Research (B) Report (Grant Number: 21390190), Japan Society for the Promotion of Science [cited 1 Feb 2018]. https://kaken.nii.ac.jp/file/KAKENHI-PROJECT-21390190/21390190seika.pdf (in Japanese).
Kiyohara C, Nakanishi Y, Inutsuka S, Takayama K, Hara N, Motohiro A, et al. The relationship between CYP1A1 aryl hydrocarbon hydroxylase activity and lung cancer in a Japanese population. Pharmacogenetics. 1998;8(4):315–23.
Kiyohara C, Horiuchi T, Takayama K, Nakanishi Y. Methylenetetrahydrofolate reductase polymorphisms and interaction with smoking and alcohol consumption in lung cancer risk: a case-control study in a Japanese population. BMC Cancer. 2011;11:459. https://doi.org/10.1186/1471-2407-11-459.
Liao SG, Liu L, Zhang YY, Wang Y, Wang YJ. SULT1A1 Arg213His polymorphism and lung cancer risk: a meta-analysis. Asian Pac J Cancer Prev. 2012;13(2):579–83.
Hosking L, Lumsden S, Lewis K, Yeo A, McCarthy L, Bansal A, et al. Detection of genotyping errors by hardy-Weinberg equilibrium testing. Eur J Hum Genet. 2004;12(5):395–9. https://doi.org/10.1038/sj.ejhg.5201164.
Gomes I, Collins A, Lonjou C, Thomas NS, Wilkinson J, Watson M, et al. Hardy-Weinberg quality control. Ann Hum Genet. 1999;63(Pt 6):535–8. https://doi.org/10.1017/S0003480099007824.
Haga H, Yamada R, Ohnishi Y, Nakamura Y, Tanaka T. Gene-based SNP discovery as part of the Japanese Millennium Genome Project: identification of 190,562 genetic variations in the human genome. Single-nucleotide polymorphism. J Hum Genet. 2002;47(11):605–10. https://doi.org/10.1007/s100380200092.
Yamaguchi-Kabata Y, Nakazono K, Takahashi A, Saito S, Hosono N, Kubo M, et al. Japanese population structure, based on SNP genotypes from 7003 individuals compared to other ethnic groups: effects on population-based association studies. Am J Hum Genet. 2008;83(4):445–56. https://doi.org/10.1016/j.ajhg.2008.08.019.
WHO. Lung cancer. In: Stewart BW, Kleihues P, editors. World cancer report. Lyon: International Agency for Research on Cancer Press; 2003. p. 182–7.
Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years’ observations on male British doctors. BMJ. 2004;328(7455):1519. https://doi.org/10.1136/bmj.38142.554479.AE.
Riscuta G. Nutrigenomics at the interface of aging, lifespan, and cancer prevention. J Nutr. 2016;146(10):1931–9. https://doi.org/10.3945/jn.116.235119.
Krabbe LM, Lotan Y. Should patients newly diagnosed with bladder cancer be screened for lung cancer? Int J Urol. 2016;23(4):346–7. https://doi.org/10.1111/iju.13052.
International Agency for Research on Cancer. Some drinking-water disinfectants and contaminants, including arsenic, vol. 84. Lyon: World Health Organization; 2004.
Hietanen E, Husgafvel-Pursiainen K, Vainio H. Interaction between dose and susceptibility to environmental cancer: a short review. Environ Health Perspect. 1997;105(Suppl 4):749–54.
Washio M. Editorial comment to should patients newly diagnosed with bladder cancer be screened for lung cancer? Int J Urol. 2016;23(4):347. https://doi.org/10.1111/iju.13064.
Truong T, Sauter W, McKay JD, Hosgood HD 3rd, Gallagher C, Amos CI, et al. International Lung Cancer Consortium: coordinated association study of 10 potential lung cancer susceptibility variants. Carcinogenesis. 2010;31(4):625–33. https://doi.org/10.1093/carcin/bgq001.
Hung RJ, Christiani DC, Risch A, Popanda O, Haugen A, Zienolddiny S, et al. International Lung Cancer Consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways. Cancer Epidemiol Biomarkers Prev. 2008;17(11):3081–9. https://doi.org/10.1158/1055-9965.Epi-08-0411.
Kiyohara C, Yoshimasu K, Takayama K, Nakanishi Y. Lung cancer susceptibility: are we on our way to identifying a high-risk group? Future Oncol (London, England). 2007;3(6):617–27. https://doi.org/10.2217/14796694.3.6.617.
Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74–108.
Sun S, Schiller JH, Gazdar AF. Lung cancer in never smokers—a different disease. Nat Rev Cancer. 2007;7(10):778–90. https://doi.org/10.1038/nrc2190.
Cote ML, Liu M, Bonassi S, Neri M, Schwartz AG, Christiani DC, et al. Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium. Eur J Cancer. 2012;48(13):1957–68. https://doi.org/10.1016/j.ejca.2012.01.038.
Jamrozik K. Tobacco and cardiovascular disease. In: Boyle P, Gray N, Henningfield J, Seffrin J, Zatonski W, editors. Tobacco and public health: science and policy. New York: Oxford University Press Inc.; 2004. p. 549–76. ISBN: 0-19-852687-3.
Washio M, Kiyohara C, Morioka S, Mori M. The experiences of smoking in school children up to and including high school ages and the current status of smoking habits; a survey of male high school students in Japan. Asian Pac J Cancer Prev. 2003;4:344–51.
Washio M, Kiyohara C, Oura A, Mori M. Smoking in youth: a review. In: Lapointe MM, editor. Adolescent smoking and health research. New York: Nova Science Publishers Inc.; 2008. p. 191–205. ISBN: 987-1-60456-046-6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Kiyohara, C., Nakanishi, Y., Washio, M. (2019). Lung Cancer in the Elderly: The Most Dominant Cause of Cancer Death in Japan. In: Washio, M., Kiyohara, C. (eds) Health Issues and Care System for the Elderly. Current Topics in Environmental Health and Preventive Medicine. Springer, Singapore. https://doi.org/10.1007/978-981-13-1762-0_11
Download citation
DOI: https://doi.org/10.1007/978-981-13-1762-0_11
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-1761-3
Online ISBN: 978-981-13-1762-0
eBook Packages: MedicineMedicine (R0)